Free Trial
LON:DXRX

Diaceutics (DXRX) Share Price, News & Analysis

Diaceutics logo
GBX 137.50 0.00 (0.00%)
As of 12:30 PM Eastern

About Diaceutics Stock (LON:DXRX)

Key Stats

Today's Range
137.10
137.70
50-Day Range
112.50
140
52-Week Range
106
151
Volume
334,198 shs
Average Volume
146,093 shs
Market Capitalization
£116.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
GBX 175
Consensus Rating
Buy

Company Overview

Receive DXRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Diaceutics and its competitors with MarketBeat's FREE daily newsletter.

DXRX Stock News Headlines

FOUR TRILLION DOLLARS!
Nvidia just became the first company in history to hit a $4 trillion valuation—surpassing Apple and Microsoft. But one controversial analyst, known for predicting the collapses of Fannie Mae, GM, and others, is issuing a serious warning. He believes Nvidia’s rise has masked a dangerous flaw—and that the stock could fall 50% or more from current levels.
See More Headlines

DXRX Stock Analysis - Frequently Asked Questions

Diaceutics' stock was trading at GBX 123 on January 1st, 2025. Since then, DXRX shares have increased by 11.8% and is now trading at GBX 137.50.

Diaceutics PLC (LON:DXRX) released its quarterly earnings results on Tuesday, May, 13th. The company reported ($2.02) earnings per share (EPS) for the quarter. Diaceutics had a negative net margin of 10.90% and a negative trailing twelve-month return on equity of 7.15%.

Shares of DXRX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Diaceutics investors own include 4D pharma (DDDD), Rolls-Royce Holdings plc (RR.L), Abcam (ABC), B&M European Value Retail (BME), BP (BP), Coats Group (COA) and genedrive (GDR).

Company Calendar

Last Earnings
5/13/2025
Today
8/08/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
LON:DXRX
CIK
N/A
Phone
N/A
Fax
N/A
Employees
151
Year Founded
N/A

Price Target and Rating

High Price Target
GBX 185
Low Price Target
GBX 160
Potential Upside/Downside
+27.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
GBX (3.37)
Trailing P/E Ratio
N/A
Forward P/E Ratio
136.03
P/E Growth
N/A
Net Income
-£2.84 million
Net Margins
-10.90%
Pretax Margin
N/A
Return on Equity
-7.15%
Return on Assets
-6.06%

Debt

Debt-to-Equity Ratio
0.39
Current Ratio
4.85
Quick Ratio
9.92

Sales & Book Value

Annual Sales
£26.08 million
Price / Sales
4.45
Cash Flow
GBX 44.07 per share
Price / Cash Flow
3.12
Book Value
GBX 45.87 per share
Price / Book
3.00

Miscellaneous

Outstanding Shares
84,393,829
Free Float
N/A
Market Cap
£116.04 million
Optionable
Not Optionable
Beta
0.58
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (LON:DXRX) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners